Moreover, MYCN amplification and age at diagnosis that represent important prognostic factors were not related to sHLA-G and sHLA-E levels in BM, thus further suggesting that these molecules might be released by BM stromal cells or BM resident cell populations instead of NB cells themselves, and may be present in the BM environment in physiological conditions. The gene discussed is MYCN; the disease is neuroblastoma.